| HOME >> BIOLOGY >> TECHNOLOGY |
standards Deferred transaction costs are netted against the
convertible royalty participation units in liabilities.
STATEMENTS OF LOSS,
COMPREHENSIVE LOSS AND
DEFICIT
Unaudited - In Thousands Three months ended Six months ended
Canadian dollars (except October 31, October 31,
per share amounts) 2007 2006 2007 2006
----------------------------------------------
Revenue
Research and development
collaboration - - 6 -
-------------------------------------------------------------------------
$ - $ - $6 $ -
-------------------------------------------------------------------------
Expenses
Research and development 1,754 2,165 3,457 3,506
General and corporate 843 1,016 1,830 1,805
Amortization 117 233 254 459
-------------------------------------------------------------------------
$2,714 $3,414 $5,541 $5,770
-------------------------------------------------------------------------
Loss before other income
(expense) $(2,714) $(3,414) $(5,535) $(5,770)
Accretion of convertible
royalty participation
units (425) (419) (846) (719)
Interest income 127 130 270 274
Foreign exchange gain
(loss) 15 (9) 14 17
-------------------------------------------------------------------------
Loss and comprehensive
loss for the period $(2,997) $(3,7
'/>"/>
| SOURCE MIGENIX Inc. Copyright©2007 PR Newswire. All rights reserved |